The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 24, 2020

Filed:

Oct. 23, 2018
Applicant:

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

James J. Collins, Newton, MA (US);

Michael Andrew Lobritz, Basel, CH;

Arnaud Gutierrez, Somerville, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/26 (2006.01); A61K 31/194 (2006.01); A61K 31/496 (2006.01); A61K 33/00 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61P 31/04 (2006.01); A61K 31/4709 (2006.01); A61K 31/4741 (2006.01); A61K 31/4745 (2006.01); A61K 31/5383 (2006.01); A61K 31/7004 (2006.01);
U.S. Cl.
CPC ...
A61K 47/26 (2013.01); A61K 31/194 (2013.01); A61K 31/4709 (2013.01); A61K 31/4741 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/5383 (2013.01); A61K 31/7004 (2013.01); A61K 33/00 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61P 31/04 (2018.01);
Abstract

Provided herein are pharmaceutical compositions and kits useful for sensitizing a microorganism or a population of microorganisms to a quinolone antibiotic. In a particular aspect, a carbon source and an electron acceptor can sensitize an antibiotic persistent microorganism to treatment with a fluoroquinolone antibiotic. Methods for sensitizing a microorganism to a quinolone antibiotic, reducing the density-dependent persistence (DDP) of an antibiotic resistant microorganism, and reducing the number of persistent cells in a population are also provided. Theses compositions and methods are useful in treating infections resulting from high-density bacterial cultures, such as pneumonia, genitourinary infections, biofilms, prosthetic graft infections, sepsis, and endovascular infections.


Find Patent Forward Citations

Loading…